FF
RPRX icon

FourThought Financial’s Royalty Pharma RPRX Stock Holding History

FourThought Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
12
– – ﹤0.01% 1559
2022
Q2 		$1K Hold
12
– – ﹤0.01% 1431
2022
Q1 		$0 Hold
12
– – ﹤0.01% 1551
2021
Q4 		$0 Buy
+12
New +$466 ﹤0.01% 1561

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

FourThought Financial's RPRX Position: Q3 2022 in Review

FourThought Financial held its Royalty Pharma (RPRX) position steady in Q3 2022 at 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

FourThought Financial first reported a position in RPRX in Q4 2021 and has held it in 4 quarters since. The position peaked at $1K in Q2 2022. 319 funds tracked by Wall St. Rank hold RPRX as of Q3 2022.

  • FourThought Financial held 12 shares of Royalty Pharma worth $0 as of Q3 2022.
  • FourThought Financial left its Royalty Pharma share count unchanged in Q3 2022.
  • Royalty Pharma made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1559 holding.
  • FourThought Financial first reported a position in Royalty Pharma in Q4 2021 and has held it in 4 quarters since.
  • FourThought Financial's Royalty Pharma position peaked at $1K in Q2 2022.
  • 319 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.